Regulatory and market intelligence for the e-cigarette sector
Despite the aim of the 2018 US Farm Bill being to restrict the ability to make intoxicating substances from hemp, there are a number of companies that are selling intoxicating cannabinoid products, doing so by claiming legality under the Farm Bill. Such products tend to be sold in the form of vapes or gummies. This report looks at some of the most common intoxicating cannabinoid products on the US market and examines their legality under federal law.
If you purchase a report that is updated in the next 60 days, we will send you the new report for free.
Reasons to buyIf you have interest in the US market, and more specifically in the novel products that are rapidly appearing, then this is the report for you. It examines the current legislation in place for such products, along with its implications, the legal framework and how these products fall within existing law. It also discusses the possible future regulation and enforcement that could be brought in to control the increasing number of new substances on the market.
Table of contents1 Executive summary
2 Legislation effects and implications
3 Legal framework
4 Safety concerns
5 Enforcement coming?
MethodologyThe research is completely original and conducted by ECigIntelligence’s multilingual legal analysis team using several sources, including: online and offline resources and data, specialist legal software, interviews with key stakeholders and government officials, and via the collaboration with local lawyers and on-the-ground professionals.
Latest reportsDespite the aim of the 2018 US Farm Bill being to restrict the ability to make intoxicating substances from hemp, there are a number of companies that are selling intoxicating cannabinoid products, doing so by claiming legality under the Farm Bill. Such products tend to be sold in the form of vapes or gummies. This report looks at some of the most common intoxicating cannabinoid products on the US market and examines their legality under federal law.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.